TY - JOUR
T1 - APOE genotype and nonrespiratory sleep parameters in cognitively intact older adults
AU - Spira, Adam P.
AU - An, Yang
AU - Peng, Yu
AU - Wu, Mark N.
AU - Simonsick, Eleanor M.
AU - Ferrucci, Luigi
AU - Resnick, Susan M.
N1 - Publisher Copyright:
© 2017 Oxford University Press. All Rights Reserved.
PY - 2017/8
Y1 - 2017/8
N2 - Study Objectives: The apolipoprotein E (APOE) ϵ4 allele increases Alzheimer's disease (AD) risk and has been linked to a greater risk of sleep-disordered breathing. We investigated the association of APOE genotype with nonrespiratory sleep parameters. Methods: We studied 1264 cognitively normal participants in the Baltimore Longitudinal Study of Aging (mean = 57.5 ± 16.1 years, range 19.9-92.0, 48.2% women, 19.8% African American) with APOE genotyping and self-reported sleep duration (≥9, 7 or 8, ≤6 hours), difficulty falling/staying asleep, and napping. We compared ϵ4 carriers with all noncarriers and compared persons at reduced (ϵ2/ϵ2 or ϵ2/ϵ3) or elevated AD risk (≥1 ϵ4 allele) with those neutral for AD risk (ϵ3/ϵ3). Results: In fully adjusted models, those with ≥1 ϵ4 allele had a greater odds of being in a shorter sleep duration category compared to all noncarriers (odds ratio [OR] = 1.41, 95% confidence interval [CI] 1.06, 1.88) and ϵ3/ϵ3 carriers (OR = 1.43, 95% CI 1.06, 1.92). Compared to ϵ3/ϵ3 carriers, ϵ2/ϵ2 or ϵ2/ϵ3 carriers had a lower odds of reporting napping (OR = 0.64, 95% CI 0.43, 0.96). Among participants aged ≥50 years, sleep duration findings remained and ϵ4 carriers had a greater odds of trouble falling/staying asleep than noncarriers (OR = 1.49, 95% CI 1.02, 2.17). We found some evidence for stronger associations of ϵ4 with sleep duration among African Americans. Conclusions: Self-reported sleep duration, napping, and trouble falling/staying asleep differ by APOE genotype. Studies are needed to examine whether APOE promotes AD by degrading sleep and to clarify the role of race in these associations.
AB - Study Objectives: The apolipoprotein E (APOE) ϵ4 allele increases Alzheimer's disease (AD) risk and has been linked to a greater risk of sleep-disordered breathing. We investigated the association of APOE genotype with nonrespiratory sleep parameters. Methods: We studied 1264 cognitively normal participants in the Baltimore Longitudinal Study of Aging (mean = 57.5 ± 16.1 years, range 19.9-92.0, 48.2% women, 19.8% African American) with APOE genotyping and self-reported sleep duration (≥9, 7 or 8, ≤6 hours), difficulty falling/staying asleep, and napping. We compared ϵ4 carriers with all noncarriers and compared persons at reduced (ϵ2/ϵ2 or ϵ2/ϵ3) or elevated AD risk (≥1 ϵ4 allele) with those neutral for AD risk (ϵ3/ϵ3). Results: In fully adjusted models, those with ≥1 ϵ4 allele had a greater odds of being in a shorter sleep duration category compared to all noncarriers (odds ratio [OR] = 1.41, 95% confidence interval [CI] 1.06, 1.88) and ϵ3/ϵ3 carriers (OR = 1.43, 95% CI 1.06, 1.92). Compared to ϵ3/ϵ3 carriers, ϵ2/ϵ2 or ϵ2/ϵ3 carriers had a lower odds of reporting napping (OR = 0.64, 95% CI 0.43, 0.96). Among participants aged ≥50 years, sleep duration findings remained and ϵ4 carriers had a greater odds of trouble falling/staying asleep than noncarriers (OR = 1.49, 95% CI 1.02, 2.17). We found some evidence for stronger associations of ϵ4 with sleep duration among African Americans. Conclusions: Self-reported sleep duration, napping, and trouble falling/staying asleep differ by APOE genotype. Studies are needed to examine whether APOE promotes AD by degrading sleep and to clarify the role of race in these associations.
KW - APOE
KW - Genotype
KW - Napping
KW - Older adults
KW - Sleep
UR - http://www.scopus.com/inward/record.url?scp=85033373984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033373984&partnerID=8YFLogxK
U2 - 10.1093/sleep/zsx076
DO - 10.1093/sleep/zsx076
M3 - Article
C2 - 28482100
AN - SCOPUS:85033373984
SN - 0161-8105
VL - 40
SP - 1
EP - 8
JO - Sleep
JF - Sleep
IS - 8
ER -